Cargando…
Unsachgemäße Systemtherapie bei schwerer atopischer Dermatitis – fatale Langzeitschäden
The therapeutic options for treatment of severe cases of atopic dermatitis have been limited until recently, but fundamentally improved with the approval of the first biological dupilumab at the end of 2017. With the biological tralokinumab and the Janus kinase inhibitors baricitinib and upadacitini...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358965/ https://www.ncbi.nlm.nih.gov/pubmed/34905073 http://dx.doi.org/10.1007/s00105-021-04922-1 |